基本信息
浏览量:21
职业迁徙
个人简介
Dr. Yuan studies the mechanisms of opioid actions, especially the antagonism of opioid side effects. He performed clinical development of methylnaltrexe, a novel compound subsequently approved by the FDA for opioid-induced constipation in advanced illness patients. The FDA approved the methylnaltrexe for the treatment of opioid-induced constipation in patients with chronic non-cancer pain in 2014, and its oral tablets in 2016. This new drug now has been approved for use in over 60 countries worldwide. Dr. Yuan also has a specific interest in herbal medicine research, and serves as the Editor-in-Chief of the American Journal of Chinese Medicine. One of his research interests is to investigate the role of the enteric microbiome in cancer prevention and human health in relation to dietary supplement consumption.
研究兴趣
论文共 482 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of ethnopharmacology (2024): 116878-116878
Journal of Controlled Release (2024): 780-796
Chemical Engineering Journalpp.151838, (2024)
Cancer chemotherapy and pharmacologyno. 5 (2024): 1-15
Frontiers in Chemistry (2024)
BMJ-BRITISH MEDICAL JOURNAL (2024): e076410-e076410
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn